Literature DB >> 6380620

Marrow harvesting from normal donors.

C D Buckner, R A Clift, J E Sanders, P Stewart, W I Bensinger, K C Doney, K M Sullivan, R P Witherspoon, H J Deeg, F R Appelbaum.   

Abstract

The experience at a single institution in harvesting marrow for allogeneic transplantation on 1,270 occasions from 1,160 normal donors is presented in detail, together with an analysis of all the donor complications. Four donors were less than 2 years old, and the youngest was 6 1/2 months. No special difficulties were encountered with these young donors. Hospitalization time was three days or less for 99% of the procedures. Six donors had life-threatening complications; three of a cardiopulmonary and two of an infectious nature, and one cerebrovascular embolic episode. Significant operative site morbidity, usually transient neuropathies, occurred in ten procedures. Ten percent of the donations were associated with transient postoperative fever of unknown origin. Increasing donor age was associated with a reduction of the cellularity of the marrow harvest. The use of stored autologous blood permitted the avoidance of blood bank transfusion in 81% of males, 69% of females, and 50% of children. It was concluded that the procedure was associated with a very low risk of complication, but that the involvement of normal donors in such an operation justifies stringent monitoring.

Entities:  

Mesh:

Year:  1984        PMID: 6380620

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  Stem cell bioprocessing: fundamentals and principles.

Authors:  Mark R Placzek; I-Ming Chung; Hugo M Macedo; Siti Ismail; Teresa Mortera Blanco; Mayasari Lim; Jae Min Cha; Iliana Fauzi; Yunyi Kang; David C L Yeo; Chi Yip Joan Ma; Julia M Polak; Nicki Panoskaltsis; Athanasios Mantalaris
Journal:  J R Soc Interface       Date:  2009-03-06       Impact factor: 4.118

2.  Predictors of Mononuclear Cell Yield in Patients Undergoing Autologous Mononuclear Stem Cell Therapy in Non-haemopoietic Degenerative Disorders.

Authors:  Deepak Pahwa; Ratti Ram Sharma; Neelam Marwaha
Journal:  Indian J Hematol Blood Transfus       Date:  2017-07-26       Impact factor: 0.900

Review 3.  G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept.

Authors:  U Deotare; G Al-Dawsari; S Couban; J H Lipton
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483

4.  Isolation and characterization of multipotent mesenchymal stem cells in nasal polyps.

Authors:  Jung-Sun Cho; Joo-Hoo Park; Ju-Hyung Kang; Sung Eun Kim; Il-Ho Park; Heung-Man Lee
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-06

5.  Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.

Authors:  Michael A Pulsipher; Brent R Logan; Deidre M Kiefer; Pintip Chitphakdithai; Marcie L Riches; J Douglas Rizzo; Paolo Anderlini; Susan F Leitman; James W Varni; Hati Kobusingye; RaeAnne M Besser; John P Miller; Rebecca J Drexler; Aly Abdel-Mageed; Ibrahim A Ahmed; Edward D Ball; Brian J Bolwell; Nancy J Bunin; Alexandra Cheerva; David C Delgado; Christopher C Dvorak; Alfred P Gillio; Theresa E Hahn; Gregory A Hale; Ann E Haight; Brandon M Hayes-Lattin; Kimberly A Kasow; Michael Linenberger; Margarida Magalhaes-Silverman; Shahram Mori; Vinod K Prasad; Troy C Quigg; Indira Sahdev; Jeffrey R Schriber; Shalini Shenoy; William T Tse; Gregory A Yanik; Willis H Navarro; Mary M Horowitz; Dennis L Confer; Bronwen E Shaw; Galen E Switzer
Journal:  Biol Blood Marrow Transplant       Date:  2018-12-31       Impact factor: 5.742

6.  Feasibility of marrow harvesting from pediatric sibling donors without hematopoietic growth factors and allotransfusion.

Authors:  M Yabe; T Morimoto; T Shimizu; T Koike; H Takakura; K Ohtsubo; A Fukumura; S Kato; H Yabe
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

Review 7.  Principles and overview of allogeneic hematopoietic stem cell transplantation.

Authors:  Sergio Giralt; Michael R Bishop
Journal:  Cancer Treat Res       Date:  2009

8.  Severe events in donors after allogeneic hematopoietic stem cell donation.

Authors:  Joerg Halter; Yoshihisa Kodera; Alvaro Urbano Ispizua; Hildegard T Greinix; Norbert Schmitz; Geneviève Favre; Helen Baldomero; Dietger Niederwieser; Jane F Apperley; Alois Gratwohl
Journal:  Haematologica       Date:  2008-12-04       Impact factor: 9.941

9.  Monoclonal gammopathy of unknown significance in a bone marrow donor.

Authors:  S O Peters; M Stockschläder; W Zeller; K Mross; M Dürken; W Krüger; A R Zander
Journal:  Ann Hematol       Date:  1993-02       Impact factor: 3.673

10.  Registry of unrelated bone marrow donors.

Authors:  G Rock; F Decary; N McCombie; R K Smiley; M T Aye; L Huebsch
Journal:  CMAJ       Date:  1987-08-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.